Impact of malodour on health‐related quality of life of patients with chronic wounds due to volatile organic compounds
Wound Repair and Regeneration · 2025
DOI: 10.1111/wrr.70033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Wound Repair and Regeneration, 2025. Verfasst von E K Stuermer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Medicine, Translational Wound Research, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany. Hauptthemen laut MEDLINE: Quality of Life, Volatile Organic Compounds, Odorants, Wound Healing. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Wundversorgung
Abstract (Originalsprache)
Chronic wounds significantly impact health‐related quality of life (HRQoL). Unpleasant wound odour, caused by bacterial colonisation and necrotic processes, is a distressing symptom. Its exact composition is not well understood, but it could be the basis for a personalised odour avoidance strategy. Therefore, this feasibility study explored 92 wounds from 66 patients with the focus on wound odour, bacterial burden and their impact on health related‐quality of life (HRQoL). Volatile organic compounds (VOCs) responsible for wound odours were detected at the molecular level, using gas chromatography–mass spectrometry and ‐ion mobility spectrometry and correlated to the HRQoL. In patients analysed (average age 69 ± 13 years, wound persistence 24.31 ± 70.8 months) 135 pathogens were identified by swabbing including 19% Staphylococcus aureus , 15% Pseudomonas aeruginosa and 35% Enterobacteria . The specific questionnaire ‘Wound‐QoL‐14’ showed a non‐significant difference in HRQoL in patients with wound odour (2.1 ± 1.0 vs. 1.8 ± 1.0). The latter also had the highest number of VOC detections. The most frequently detected, relevant VOCs from prokaryotic sources were dimethyl‐disulphide and diacetyl‐(2,3‐butanedione). Furthermore, potential biomarkers for specific pathogens were identified, including dimethyl‐trisulphide for P. aeruginosa and indole for Escherichia coli . The most prevalent substance groups were ketones and alcohols. In conclusion, the malodour of chronic wounds is caused by a mixture of the intrinsic odour of bacterial products and necrosis. This exploratory study, which combines the analysis of decoded VOCs and the olfactory assessment of odour, could be a novel, targeted approach for identifying potential ‘anti‐wound odour therapies’ that will significantly benefit the HRQoL of patients with malodourous tumour wounds, in particular.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Vascular Medicine, Translational Wound Research, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
- Hamm-Lippstadt University of Applied Sciences, Hamm, Germany.
- Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
ORCID-Profile: M Wigger, T M Janke, M Augustin
Zitieren
APA
Stuermer, E. K., Nathrath, C., Lober, H., Wigger, M., Janke, T. M., Augustin, M., Dittmer, M., Sielemann, S., & Liegenfeld, S. C. (2025). Impact of malodour on health‐related quality of life of patients with chronic wounds due to volatile organic compounds. Wound Repair and Regeneration. https://doi.org/10.1111/wrr.70033
Vancouver
Stuermer EK, Nathrath C, Lober H, Wigger M, Janke TM, Augustin M, et al. Impact of malodour on health‐related quality of life of patients with chronic wounds due to volatile organic compounds. Wound Repair and Regeneration. 2025. doi:10.1111/wrr.70033
BibTeX
@article{Stuermer2025,
author = {Stuermer, E K and Nathrath, C and Lober, H and Wigger, M and Janke, T M and Augustin, M and Dittmer, M and Sielemann, S and Liegenfeld, S C},
title = {Impact of malodour on health‐related quality of life of patients with chronic wounds due to volatile organic compounds},
journal = {Wound Repair and Regeneration},
year = {2025},
doi = {10.1111/wrr.70033}
}
EUVIMED